HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Foroogh Nejatollahi Selected Research

Single-Chain Antibodies

7/2020Anti-Proliferative Effect of Specific Anti-EGFR Single Chain Antibody on Triple Negative Breast Cancer Cells.
10/2019Isolation of Neutralizing Human Single Chain Antibodies Against Conserved Hemagglutinin Epitopes of Influenza a Virus H3N2 Strain.
4/2019Generation and characterization of a specific single-chain antibody against DSPP as a prostate cancer biomarker: Involvement of bioinformatics-based design of novel epitopes.
10/2018Selection and Evaluation of Specific Single Chain Antibodies against CD90, a Marker for Mesenchymal and Cancer Stem Cells.
10/2017Production and Evaluation of Specific Single-Chain Antibodies against CTLA-4 for Cancer-Targeted Therapy.
3/2016Single Chain Antibodies Against gp55 of Human Cytomegalovirus (HCMV) for Prophylaxis and Treatment of HCMV Infections.
12/2014Induction of anti-proliferative and apoptotic effects by anti-IL-25 receptor single chain antibodies in breast cancer cells.
8/2014Triple blockade of HER2 by a cocktail of anti-HER2 scFv antibodies induces high antiproliferative effects in breast cancer cells.
1/2013Antiproliferative and apoptotic effects of a specific antiprostate stem cell single chain antibody on human prostate cancer cells.
3/2012Down-regulation of vascular endothelial growth factor expression by anti-Her2/neu single chain antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Foroogh Nejatollahi Research Topics

Disease

14Neoplasms (Cancer)
07/2022 - 03/2012
6Breast Neoplasms (Breast Cancer)
06/2018 - 03/2012
4Prostatic Neoplasms (Prostate Cancer)
04/2019 - 01/2013
2Human Influenza (Influenza)
01/2021 - 10/2019
2Triple Negative Breast Neoplasms
07/2020 - 06/2018
2Infections
01/2017 - 03/2016
1Melanoma (Melanoma, Malignant)
05/2021
1Glioblastoma (Glioblastoma Multiforme)
01/2017
1Adenocarcinoma
08/2015
1Ovarian Neoplasms (Ovarian Cancer)
08/2015
1Neoplasm Metastasis (Metastasis)
08/2015
1Carcinoma (Carcinomatosis)
08/2015

Drug/Important Bio-Agent (IBA)

10Single-Chain AntibodiesIBA
07/2020 - 03/2012
9AntibodiesIBA
07/2022 - 03/2012
5EpitopesIBA
07/2022 - 01/2017
5AntigensIBA
07/2022 - 01/2013
4Monoclonal AntibodiesIBA
10/2019 - 01/2017
4Proteins (Proteins, Gene)FDA Link
06/2018 - 01/2013
2ErbB Receptors (EGF Receptor)IBA
07/2020 - 08/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2015 - 03/2012
2human ERBB2 proteinIBA
08/2014 - 01/2013
1Receptor Tyrosine Kinase-like Orphan ReceptorsIBA
07/2022
1Hemagglutinins (Hemagglutinin)IBA
10/2019
1Biomarkers (Surrogate Marker)IBA
04/2019
1CateninsIBA
06/2018
1Neutralizing AntibodiesIBA
01/2017
1LigandsIBA
01/2017
1Cell Surface ReceptorsIBA
01/2017
1Annexin A5IBA
01/2017
1ParaffinIBA
08/2015
1pertuzumabIBA
08/2014
1Trastuzumab (Herceptin)FDA Link
08/2014
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2013
1Epidermal Growth Factor (EGF)IBA
01/2013

Therapy/Procedure

11Immunotherapy
07/2022 - 12/2014
7Therapeutics
07/2022 - 01/2013
1Precision Medicine
05/2021
1Photothermal Therapy
05/2021